image
Fennec Pharmaceuticals Inc. FENC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.11
-4.3 %
$ 169 M
Market Cap
-300.5
P/E
CASH FLOW STATEMENT
27 M OPERATING CASH FLOW
257.38%
Growth Rates
1Year 257.38%
3Years 57.37%
5Years 37.85%
7Years 37.75%
10Years 33.42%
0 INVESTING CASH FLOW
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-13.6 M FINANCING CASH FLOW
-205.11%
Growth Rates
1Year -205.11%
3Years -55.15%
5Years -186.12%
7Years -5.83%
10Years -21.15%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Fennec Pharmaceuticals Inc.
image
30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -70 K
Depreciation & Amortization 800 K
Capital Expenditures 0
Stock-Based Compensation 5.06 M
Change in Working Capital 16.1 M
Others 21.2 M
Free Cash Flow 27 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000
OPERATING CASH FLOW
Net Income 70 K (16.0) (23.7) (17.3) (18.1) (12.8) (9.9) (7.0) (2.8) (0.7) (2.2) 1.8 (5.2) 4.7 (7.8) (3.0) (13.6) (13.4) (19.1) (19.2) (8.7) (6.1) (3.7) (2.5) (1.6)
Depreciation & Amortization 0.8 0 0.1 14 K 0.4 64 K 0 0 0 0 0 0 0 0 0 0 0.2 0.2 2.4 3.1 2.5 1.6 0.1 55.2 K 52 K
Deferred Income Tax 0 0 0 14 K (0.4) 64 K 0 0 0 0 0 0 0 0 0 0 0 0 (1.5) 0 0 0 0 0 0
Stock Based Compensation 5.1 5.4 4.2 4.0 2.9 3.1 1.8 1.5 0.6 97 K 0.6 87 K 0.3 0.2 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 5.1 0.3 0.3 0.3 0.5 0.5 0.1 0.9 40 K (1.2) (0.3) (3.8) 1.6 (8.1) 5.8 0.2 2.5 2.3 2.6 2.9 (0.4) (0.3) 0 0.000001 30.4 K
Change in Working Capital 16.1 (6.8) 1.1 (0.9) (0.8) 0.6 0.1 1.0 10 K 63 K 0.1 (0.4) 0.3 81 K 0.1 (1.9) 0.1 (2.5) 2.1 1.0 0.6 (0.6) 0.4 (0.3) 0.4
Cash From Operations 27.0 (17.1) (18.1) (14.2) (15.6) (9.1) (7.8) (3.6) (2.1) (1.9) (1.7) (2.2) (3.0) (3.2) (1.9) (4.7) (10.8) (13.3) (13.5) (12.3) (6.0) (5.4) (3.2) (2.7) (1.2)
INVESTING CASH FLOW
Capital Expenditures 0 2.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15 K 73 K 5 K (0.1) (0.2) 69.8 K (0.3) (0.3) 32.3 K
Other Items 0 2.75 0 0 0 0 0 0 0 0 0 0 0 0 0 24 K 0 2 K 1.2 (1.2) (6.9) 5.2 (5.5) 8.4 K 0
Cash From Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24 K 15 K 75 K 1.2 (1.3) (7.1) 5.1 (5.8) (0.3) 32.3 K
FINANCING CASH FLOW
Common Stock Repurchased 0 78 K (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (13.0) 5.0 19.9 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 40 K 28 K 59 K 0 1.3 1.9 33 K 24.3 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.6) 1.6 0.8 22 K 0.3 71 K 2.3 0.6 0.1 0.5 0.2 0 0 0 0 0 7 K 0 70 K (0.1) 24.6 (0.4) 0.409 0 0.0918
Cash From Financing Activities (13.6) 6.6 20.7 5.0 32.3 71 K 2.3 28.0 5.1 0.5 2.3 1.6 0 2.6 7.2 0 7 K 23.9 6.1 8.0 24.6 2.2 33.3 K 12.3 1.3
CHANGE IN CASH
Net Change In Cash 13.4 (10.5) 2.7 (9.2) 16.7 (9.1) (5.5) 24.3 3.0 (1.4) 0.6 (0.6) (3.0) (0.7) 5.3 (4.7) (10.8) 10.5 (6.3) (5.6) 11.5 1.9 (9.1) 9.2 24.3 K
FREE CASH FLOW
Free Cash Flow 27.0 (17.1) (18.1) (14.2) (15.6) (9.1) (7.8) (3.6) (2.1) (1.9) (1.7) (2.2) (3.0) (3.2) (1.9) (4.7) (10.8) (13.4) (13.5) (12.4) (6.1) (5.5) (3.5) (3.0) (1.3)